SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/284484"
 

Search: onr:"swepub:oai:gup.ub.gu.se/284484" > Asthma progression ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Asthma progression and mortality: the role of inhaled corticosteroids

O'Byrne, P. (author)
Fabbri, Leonardo M. (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
Pavord, I. D. (author)
show more...
Papi, A. (author)
Petruzzelli, S. (author)
Lange, P. (author)
show less...
 (creator_code:org_t)
2019-05-02
2019
English.
In: European Respiratory Journal. - : European Respiratory Society (ERS). - 0903-1936 .- 1399-3003. ; 54:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Overall, asthma mortality rates have declined dramatically in the last 30 years, due to improved diagnosis and to better treatment, particularly in the 1990s following the more widespread use of inhaled corticosteroids (ICSs). The impact of ICS on other long-term outcomes, such as lung function decline, is less certain, in part because the factors associated with these outcomes are incompletely understood. The purpose of this review is to evaluate the effect of pharmacological interventions, particularly ICS, on asthma progression and mortality. Furthermore, we review the potential mechanisms of action of pharmacotherapy on asthma progression and mortality, the effects of ICS on long-term changes in lung function, and the role of ICS in various asthma phenotypes. Overall, there is compelling evidence of the value of ICS in improving asthma control, as measured by improved symptoms, pulmonary function and reduced exacerbations. There is, however, less convincing evidence that ICS prevents the decline in pulmonary function that occurs in some, although not all, patients with asthma. Severe exacerbations are associated with a more rapid decline in pulmonary function, and by reducing the risk of severe exacerbations, it is likely that ICS will, at least partially, prevent this decline. Studies using administrative databases also support an important role for ICS in reducing asthma mortality, but the fact that asthma mortality is, fortunately, an uncommon event makes it highly improbable that this will be demonstrated in prospective trials.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Keyword

lung-function decline
obstructive pulmonary-disease
sputum eosinophil
counts
air-flow obstruction
adult-onset asthma
double-blind
early
intervention
follow-up
budesonide-formoterol
severe exacerbations
Respiratory System

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
O'Byrne, P.
Fabbri, Leonardo ...
Pavord, I. D.
Papi, A.
Petruzzelli, S.
Lange, P.
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Respiratory Medi ...
Articles in the publication
European Respira ...
By the university
University of Gothenburg

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view